Alitair
develops, manufactures and distributes drugs for the treatment of cough and bronchiectasis... Read moreAlitair
develops, manufactures and distributes drugs for the treatment of cough and bronchiectasis... Read more
News
Aug 03, 2018
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Dec 06, 2017
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Jan 05, 2017
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Nov 28, 2016
BioPortfolio
Alitair: Alitair Pharmaceuticals Inc. Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 26, 2016
Business Wire
Press Release: Alitair : Global Bronchiectasis Pipeline Report 2016 - 12 Companies & Drug Profiles - Research and Markets
Jan 15, 2016
BioSpace
Alitair: Alitair Pharmaceuticals Announces Issuance Of Patent Covering Its Prescription Drug Overdose Reduction Technology, ODR
Jan 07, 2016
BioPortfolio
Alitair: Alitair Announces Issuance of Patent Covering Its Prescription Drug Overdose Reduction Technology ODR
Jan 06, 2016
Business Wire
Press Release: Alitair : Research and Markets: Bronchiectasis - Pipeline Review 2015
Oct 26, 2015
BIOPORTFOLIO
Alitair: Alitair Pharmaceuticals Inc. Selected to Present at October 2015 Cavendish Global Health Impact Forum
Oct 26, 2015
PRWEB
Press Release: Alitair : Alitair Pharmaceuticals, Inc. Selected to Present at October 2015 Cavendish Global Health Impact Forum
Alitair Competitors
1
2
3
4
5
6
7
8
9
10